March 2020- Volume 16, Issue 3

In this Issue

Diagnostics

Eyes are windows to the...brain?

Eyes are windows to the...brain?

C. Light Technologies uses retinal tracking and AI as a new tactic for neurological diagnosis

A ‘liquid’ asset

A ‘liquid’ asset

Liquid biopsy aims to accelerate biomarker-driven precision cancer therapies

Zeroing in on prostate cancer

Zeroing in on prostate cancer

Validation study recently completed on miR Scientific’s Sentinel tests

Discovery

AI and antibodies align

AI and antibodies align

Three-year collaboration capitalizes on AI to develop therapeutic monoclonal antibodies

Seeking candidates for Takeda

Seeking candidates for Takeda

Integrated drug discovery collaboration will focus on Takeda’s four core therapeutic areas

Cell by cell

Cell by cell

Researchers release a single-cell atlas examining changes in gene expression in Alzheimer’s disease beyond neurons

Aiding drug discovery

Aiding drug discovery

Almirall and Iktos announce a research collaboration for new drug design

Deactivating liver fibrosis

Deactivating liver fibrosis

UC San Diego researchers find transcription factors that can halt accumulation of liver scarring and encourage healing

Research & Development

Potent pathogens

Potent pathogens

Researchers take aim at antibiotic-resistant bacteria

Getting the skinny on glutamate

Getting the skinny on glutamate

A new sensor technique enables the measurement of glutamate usage by brain cells for the first time

One swab, many results

One swab, many results

Mawi DNA taps CosmosID to evaluate its iSwab-Microbiome sample collection offering

Take it from the top

Take it from the top

Purdue University team creates tumor model of pancreatic cancer that elucidates disease progression from the beginning

Business & Government Policy

Diabetes deterrent

Diabetes deterrent

Gene therapy approach reprograms beta cells in the pancreas

On the cutting edge

On the cutting edge

A roundup of instrumentation, software and other tools and technology news

Promoting more cancer R&D

Promoting more cancer R&D

Start Codon joins Cancer Research UK’s Entrepreneurial Programmes Initiative

Turning bad fat into good fat

Turning bad fat into good fat

Purdue alumnus makes an investment that could help curb obesity and diabetes

Contract Services

Monoclonal movements

Monoclonal movements

GHO Capital invests in FairJourney, provider of monoclonal antibody discovery services

Partners wanted for base editing platform

Partners wanted for base editing platform

Horizon wants to assess state of the technology and guide its future shape

An IP partnership

An IP partnership

Arctoris partners with Molecule to tackle the innovation crisis in drug discovery and development

Feature

AACR 2020 Show Preview: Crafting better cancer care

AACR 2020 Show Preview: Crafting better cancer care

The AACR Annual Meeting covers the best in cutting edge cancer research and care

Cancer therapies and insights up top

Cancer therapies and insights up top

A roundup of recent research and development efforts in brain and lung cancers

Commentary

Out of order: Developing solutions

Out of order: Developing solutions

As COVID-19 spreads, it can be a reminder that science and health research are community efforts, and to optimize our opportunities for success and serendipity, we must open that community as widely as we can

MARKET INSIGHT: Key happenings in various markets and pipelines

MARKET INSIGHT: Key happenings in various markets and pipelines

A roundup of various insights from London-based data and analytics company GlobalData over the past couple months in multiple sectors of pharma, biotech and life sciences

Preclinical

All that glitters

All that glitters

Clene Nanomedicine’s CNM-Au8 gold nanocrystals effectively induce remyelination in preclinical models

Cue up a potential answer to fighting tumors

Cue up a potential answer to fighting tumors

Cue Biopharma’s preclinical and translational data support potential of CUE-101 in HPV16-related malignancies

Saving the brain

Saving the brain

Study shows more effective, safer way to develop stem cells for treating brain damage

INDY inhibition attenuates diet-induced NASH

INDY inhibition attenuates diet-induced NASH

Eternygen presents data positioning mINDY inhibitors as novel therapeutic option in NASH

Clinical Trials

Fighting back against FOP

Fighting back against FOP

Regeneron reports encouraging garetosmab Phase 2 results in patients with ultra-rare bone disease

New possibilities in women’s health

New possibilities in women’s health

SCYNEXIS studies a new candidate in the fight against yeast infection

Peanut problem

Peanut problem

Company tests peanut allergy therapy for children

A good start for fosciclopirox

A good start for fosciclopirox

CicloMed shares Phase 1 results of its lead candidate in bladder cancer

Fighting COVID-19 effectively

Fighting COVID-19 effectively

Worldwide research and collaboration needed to combat the coronavirus, says GlobalData

Editor's Focus

Editor’s Focus: Let’s talk about the C-word, shall we?

Editor’s Focus: Let’s talk about the C-word, shall we?

Cancer news and events are the name of the game in much of the March issue of DDNews
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all the latest DDN news!

Latest Issue's Magazine Cover

Latest Issue  

• Volume 16 • Issue 10 • November 2020

November 2020

November 2020 Issue